Pricing Log in Create free account

Elicio Therapeutics, Inc. (ELTX) vs iBio, Inc. (IBIO)

Elicio Therapeutics, Inc. and iBio, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and iBio, Inc. are of similar size ($48.2M and $47.6M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against −66.6%. Across the 13 metrics below, iBio, Inc. leads on 10 and Elicio Therapeutics, Inc. on 3.

Valuation

Metric ELTX IBIO Biotechnology median
P/E n/m n/m 8.50
P/S 1.04 118.71 9.71
P/B 3.78 0.93 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.19 0.64
EV/Sales 0.59 (9.70) 9.21
Earnings yield (139.10%) (44.16%) (33.15%)
Free cash flow yield (125.90%) (30.24%) (25.50%)

Profitability

Metric ELTX IBIO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (774.56%) (65.70%) (56.36%)
Return on assets (124.36%) (54.04%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELTX IBIO Biotechnology median
Revenue growth (TTM) 921.02% (66.55%) 6.02%
EPS growth (last fiscal year) 39.29% 81.71% 30.26%
Revenue growth, 5-year CAGR — (42.83%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELTX IBIO Biotechnology median
Debt to equity 1.20 0.00 0.00
Current ratio 2.77 7.85 4.72
Net debt to EBITDA 0.25 2.57 0.96

Dividend

Metric ELTX IBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELTX IBIO Biotechnology median
Market cap 48.22m 47.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack